Indian equities in Wednesday's trade opened higher tracking positive Asian markets. At the open, Nifty, opened flat at 23,669 ...

Fosun Pharma continues to uphold the internationalization strategy in multiple dimensions, such as innovative R&D, licensing, manufacturing and operations as well as commercialization. In 2024, ...

The Association of Community Pharmacists of Nigeria (ACPN) has reiterated its call for the National Assembly to expedite amendments to the existing Fake Drug Act to formalize a sustainable ...

From spinning out Takeda’s China assets to acquiring South Korea’s Hugel, CBC is building a global M&A engine with execution at its core.

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune checkpoint inhibitors. These treatments, which ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

Legendary investor and famous contrarian Sir John Templeton once said, "The time of maximum pessimism is the best time to buy." The S&P 500 is down 3.7% through March 20, and though we are far ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health ...

International private equity firm Cinven has completed its previously announced sale of an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, ...